Taishi Yonezawa to Enzyme Inhibitors
This is a "connection" page, showing publications Taishi Yonezawa has written about Enzyme Inhibitors.
Connection Strength
0.042
-
IMPDH inhibition activates TLR-VCAM1 pathway and suppresses the development of MLL-fusion leukemia. EMBO Mol Med. 2023 01 11; 15(1):e15631.
Score: 0.042
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.